Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2: a cohort analysis [PDF]
, 2021 Daniel Prieto‐Alhambra +11 more
openalex +1 more source
Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study [PDF]
, 2023 Metalia Puspitasari +8 more
openalex +1 more source
Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
Journal of Postgraduate Medicine, 2021 Roca, B, Rambla, M, Roca, M Manuel
openaire +2 more sources
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
Nature Medicine, 2021 P. Tang +23 more
semanticscholar +1 more source
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine [PDF]
, 2022 Tal Patalon +6 more
openalex +1 more source
New onset of pemphigus foliaceus following
Dermatologic Therapy, 2022 Şebnem Yıldırıcı +3 more
openaire +3 more sources
Potential Adverse Cardiovascular Side Effects Following mRNA Covid-19 Vaccination [PDF]
In late 2019 and early 2020, we observed the emergence of Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), which quickly spread around the world, becoming a pandemic and global health crisis.
Strohmeier, Abigayle
core +1 more source
Immunogenicity of the
, 2021 Osnat Itzhaki Ben Zadok +15 more
openalex +1 more source
CoronaVac or BNT162b2 Vaccine as a Third Dose
American Journal of Respiratory and Critical Care Medicine, 2022 Rujittika Mungmunpuntipantip +1 more
openaire +2 more sources